Higher visit-to-visit systolic blood pressure variability early in life may predict CVD and all-cause mortality in middle age, according to research published in JAMA Cardiology on Jan. 22. 

A Massachusetts General Hospital physician was instrumental in getting two new medical emojis—an anatomically correct heart and a pair of lungs—approved for an update later this year, the Boston Globe reported Feb. 4.

A study published in JACC: Cardiovascular Interventions this month found that patients who suffer from migraines may find long-term relief after transcatheter patent foramen ovale closure.

A Seattle-based scientist has received a quarter of a million dollars to streamline MR imaging and analysis, the American Heart Association announced Jan. 29.

Medtronic has received CE mark approval in the European Union for its Cobalt and Crome implantable cardioverter-defibrillators and cardiac resynchronization therapy-defibrillators.

Another study has surfaced suggesting that meat—both processed and unprocessed—can have deleterious effects on heart health.

The largest comprehensive study of congenital heart disease to date has revealed that, despite an overall decline in mortality over the past few decades, a child’s odds of surviving a CHD diagnosis hinge on the economic health of their community.

A panel of experts from the Clinical Genome Resource are publicly disputing nine of 17 genes once thought to be linked to long QT syndrome.

A review published in Circulation: Cardiovascular Interventions Jan. 24 suggests adjunctive coronary atherectomy is a clinically useful and effective tool for treating severely calcified coronary lesions—but, in reality, it’s rarely used.

Emergency phone operators in Victoria, Australia, may soon have access to AI that could alert them to callers in cardiac arrest, ZDNet reports.